Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Explore various ways to earn cash before payday to help you manage your finances. Find quick solutions that can provide immediate relief.
22,513 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
As quantum dreams grow from labs to law and logistics, Rigetti's domestic footprint and government ties could propel ...
Tariff news rattled markets, but crypto found footing and moved higher. This piece breaks down the rebound dynamics, ...
Microsoft trades at a decade-low multiple as AI tools expand and Copilot adoption lags. Investors weigh the AI upside...
IonQ is set to report Q4 2025 earnings tonight, confronting a valuation that many analysts say risks outpacing the co...
Paramount has emerged as the apparent victor in a months-long bidding war to buy Warner Bros. Discovery’s film and TV...
Moderna and Ross Stores surged midweek on distinct catalysts: a patent settlement clearing a key overhang for Moderna...
A large fund trimmed its DigitalBridge position, sparking questions about stake moves, stock momentum, and how invest...
Artificial intelligence is reshaping medicine, from drug discovery to patient care. This article spotlights two healt...
Analysts outline a path to higher earnings for Southwest in 2026, but fuel costs and customer fees remain key risks. ...
Fastenal shows robust, tech-driven expansion while DNOW wrestles with ERP integration after a major acquisition, sett...
Nvidia trades around $199 per share as investors weigh whether the AI winner can also be a true value stock. The deba...